Search

Ovid therapeutics Inc

Avatud

SektorTervishoid

2.39 -4.78

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.31

Max

2.5300000000000002

Põhinäitajad

By Trading Economics

Sissetulek

-27M

-17M

Aktsiakasum

-0.125

Kasumimarginaal

-2,366.017

Töötajad

23

EBITDA

-4.7M

-17M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+113.2% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

12. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-60M

423M

Eelmine avamishind

7.17

Eelmine sulgemishind

2.39

Uudiste sentiment

By Acuity

50%

50%

146 / 342 Pingereas Healthcare

Ovid therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. juuni 2026, 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

24. juuni 2026, 23:52 UTC

News
Correlated Moves
Social Media

Applied Materials shares rose in after-market trading, boosted by strong earnings from Micron Technology and positive sentiment in the semiconductor sector.

24. juuni 2026, 23:52 UTC

News
Correlated Moves

Lam Research Corp shares rise in after-market trading, driven by positive sentiment from Micron Technology's strong results and broader semiconductor sector gains.

24. juuni 2026, 23:41 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, following a session marked by declines and mixed global market dynamics.

24. juuni 2026, 23:41 UTC

News
Correlated Moves

Alphabet Inc. shares are lower in after-market hours, down $1.13 to about $345.00, amid a broader decline in the Interactive Media & Services sector.

24. juuni 2026, 23:41 UTC

Event
News

Trip.com Group Ltd's stock is lower in after-market trading following a first-quarter net income decline and reduced second-quarter revenue guidance.

24. juuni 2026, 23:41 UTC

ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises in after-market trading, boosted by strong Q3 earnings from Micron Technologies and positive sentiment from tech sector recovery.

24. juuni 2026, 23:41 UTC

News
Correlated Moves

Western Digital shares rose sharply in after-hours trading following strong Q3 results from Micron Technology, which beat earnings and revenue expectations.

24. juuni 2026, 23:41 UTC

Correlated Moves
News

iShares Silver Trust is trading higher in after-market hours, reflecting recovery after recent declines despite slight decreases in gold prices.

24. juuni 2026, 23:41 UTC

Correlated Moves
News

SPDR Gold Shares advance in after-market trading despite lower gold prices and a slight decline in silver. U.S. stocks show generally higher performance.

24. juuni 2026, 23:41 UTC

Correlated Moves
News
Social Media

Qualcomm shares rose after Investor Day, doubling fiscal 2029 non-handset revenue targets to $40 billion and announcing a partnership with Meta Platforms for data center CPUs.

24. juuni 2026, 23:41 UTC

News

Comcast shares are higher after reports of its subsidiary Sky acquiring ITV's Broadcast unit for about £1.6 billion, pending legal review.

24. juuni 2026, 23:36 UTC

News

Gilead Sciences' Trodelvy receives FDA approval for first-line treatment of triple-negative breast cancer, boosting shares in after-market hours.

24. juuni 2026, 23:32 UTC

News
Event
Social Media

Micron Technology reported record third-quarter revenue of $41.46 billion and strong fourth-quarter guidance, driving shares higher in after-market trading.

24. juuni 2026, 23:31 UTC

News
Social Media

United States Oil Fund LP is trading higher in after-market hours following a larger-than-expected drop in U.S. crude oil inventories for the week.

24. juuni 2026, 23:11 UTC

Correlated Moves
News
Social Media

Meta shares rise in after-market trading following a strategic partnership with Qualcomm and government discussions on AI oversight.

24. juuni 2026, 23:06 UTC

News
Social Media

Tesla Inc shares are higher in after-market trading, supported by a multi-year agreement with NatPower for battery energy storage systems in Europe.

24. juuni 2026, 23:06 UTC

Correlated Moves
News

The iShares 7-10 Year Treasury Bond ETF is trading higher in after-market hours, reflecting routine movement near its one-month trading range.

24. juuni 2026, 23:06 UTC

News
Correlated Moves
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading, aided by strong earnings from Micron Technologies and lower oil prices this week.

24. juuni 2026, 23:05 UTC

News
Correlated Moves

The Vanguard Total Bond Market ETF is higher in after-market hours, reflecting broader market recovery amid easing concerns over U.S.-Iran negotiations affecting energy supply.

24. juuni 2026, 23:02 UTC

News
ETF Constituents

The Vanguard Growth ETF is gaining in after-market trading, supported by strong performances from AMD and KLA Corporation. Oil prices have declined below $80 per barrel.

24. juuni 2026, 23:02 UTC

News
Correlated Moves

The iShares 20+ Year Treasury Bond ETF is higher in after-market trading, buoyed by U.S. Bancorp's dividend increase and positive sentiment in fixed-income securities.

24. juuni 2026, 23:02 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF gains after-hours, supported by Micron Technology's record earnings and strong performance from top holdings.

24. juuni 2026, 23:01 UTC

News

Charter Communications Inc. gains in after-market trading, supported by positive sentiment from the Federal Reserve's stress test results and strong mobile segment growth.

24. juuni 2026, 22:51 UTC

News

Booking Holdings Inc may benefit from falling oil prices, with WTI crude below $70 and Brent at $74, potentially boosting travel demand. Shares are roughly flat in after-market trading.

24. juuni 2026, 20:07 UTC

News

Business confidence in Germany rose, lifting the EUR/ZAR higher during Wednesday's session. The Ifo index increased to 85.6 points, surpassing expectations.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

The US Dollar Index has risen, supporting higher trading in USD/DKK amid a broader trend of strength in the U.S. dollar.

24. juuni 2026, 20:06 UTC

Macro Event
News
Correlated Moves

The U.S. current account deficit widened to $226.8 billion, influencing notable volatility in the USD/CZK exchange rate, which is higher since Tuesday's close.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

The US dollar's strength drives USD/SGD higher, reflecting a flight to safety amid economic and geopolitical concerns. The pair remains near its one-month trading range.

24. juuni 2026, 20:06 UTC

News
Correlated Moves

USD/SEK is trading higher as the US Dollar Index strengthens amid a flight to safety, recovering from a midday dip while above its 20-day moving average.

Võrdlus sarnastega

Hinnamuutus

Ovid therapeutics Inc Prognoos

Hinnasiht

By TipRanks

113.2% tõus

12 kuu keskmine prognoos

Keskmine 5.33 USD  113.2%

Kõrge 7 USD

Madal 4 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Ovid therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

8

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

146 / 342 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Ovid therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial; OV825, has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat